We are live on ! Find out more
TECH icon

Bio-Techne

585 hedge funds and large institutions have $9.29B invested in Bio-Techne in 2026 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 200 increasing their positions, 224 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 65

3.53% more ownership

Funds ownership: 110.33% → 113.86% (+3.5%)

0% less funds holding

Funds holding: 586 → 585 (-1)

8% less capital invested

Capital invested by funds: $10.1B → $9.29B (-$823M)

11% less repeat investments, than reductions

Existing positions increased: 200 | Existing positions reduced: 224

33% less funds holding in top 10

Funds holding in top 10: 9 → 6 (-3)

42% less call options, than puts

Call options by funds: $56.4M | Put options by funds: $96.9M

Holders
585
Holders Change
-1
Holders Change %
-0.17%
% of All Funds
7.13%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
73
Increased
200
Reduced
224
Closed
65
Calls
$56.4M
Puts
$96.9M
Net Calls
-$40.5M
Net Calls Change
+$11.6M

TECH Hedge Fund Activity: Q1 2026 in Review

585 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2026, worth a combined $9.29B — down 8.1% from $10.1B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new TECH positions and 65 closed out — a net gain of 8 holders — while 200 added to existing stakes and 224 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $413M. The largest seller was Select Equity Group, cutting an estimated $128M.

  • 585 institutional investors held Bio-Techne (TECH) as of Q1 2026, down from 586 in Q4 2025.
  • Funds reported $9.29B of Bio-Techne stock for Q1 2026, down 8.1% quarter-over-quarter.
  • 73 funds opened new Bio-Techne positions in Q1 2026 and 65 closed out, a net change of +8 holders.
  • The largest Bio-Techne buyer in Q1 2026 was Fidelity Investments, an estimated $413M added.
  • The largest Bio-Techne seller in Q1 2026 was Select Equity Group, an estimated $128M sold.

Based on aggregated 13F filings for Q1 2026.